Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Toni M Brand

Showing results (31-40 of 33) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 33 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 5, 2018
Correction: AXL Is a Logical Molecular Target in Head and Neck Squamous Cell CarcinomaToni M Brand, Mari Iida, Andrew P Stein, et al.
Cancer Biology & Therapy|June 25, 2013
Paxillin mutations affect focal adhesions and lead to altered mitochondrial dynamics: relevance to lung cancerIchiro Kawada, Rifat Hasina, Frances E Lennon, et al.
The Journal of Experimental Medicine|January 27, 2019
Use of nonsteroidal anti-inflammatory drugs predicts improved patient survival for <i>PIK3CA</i>-altered head and neck cancerMatthew L Hedberg, Noah D Peyser, Julie E Bauman, et al.
Pageof 4

Showing results (31-40 of 33) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 33 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 5, 2018
Correction: AXL Is a Logical Molecular Target in Head and Neck Squamous Cell CarcinomaToni M Brand, Mari Iida, Andrew P Stein, et al.
Cancer Biology & Therapy|June 25, 2013
Paxillin mutations affect focal adhesions and lead to altered mitochondrial dynamics: relevance to lung cancerIchiro Kawada, Rifat Hasina, Frances E Lennon, et al.
The Journal of Experimental Medicine|January 27, 2019
Use of nonsteroidal anti-inflammatory drugs predicts improved patient survival for <i>PIK3CA</i>-altered head and neck cancerMatthew L Hedberg, Noah D Peyser, Julie E Bauman, et al.
Pageof 4